It's time to start planning #NephMadness 2027!
We would love your input as we start planning next year's tournament. Share your ideas:
bit.ly/NM27Ideas
@nephrosparks.bsky.social @annaburgner.bsky.social @kidneywars.bsky.social @catochita.bsky.social @ajkd.bsky.social
Short-term discontinuation due to adverse events was lowest for #ARB monotherapy and ARB plus calcium channel blocker regimens, compared with placebo. Combination therapies generally showed greater tolerability than monotherapies.
ja.ma/436Phd6
c.org/vftVj6xXHs
NephMadness
We need to make sure this editorial goes viral
Misguided Brushes of a Pen Continue to Dismantle and Destroy Biomedical Research in the United States: We Can No Longer Afford Complacency and Fear. We Must All Act Now!
diabetesjournals.org/care/article...
Final GFR results from Atrasentan (ALIGN) in the Lancet
Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH
www.thelancet.com/journals/lan...
Simulpubs from #ERA26
JAMA
We have multiple faculty positions open at UMN, one is research intensive, the other is primarily clinical. Feel free to reach out if interested or see the links below!
umphysicians.wd1.myworkdayjobs.com/en-US/umpcar...
umphysicians.wd1.myworkdayjobs.com/en-US/umpcar...
Rumor that the @amdiabetesassn.bsky.social is standing with …..the administration and denouncing their 5 colleagues (including the EiC of Diabetes Care) for violating ‘code of conduct’
Maybe the attendees should walk out. This is disgraceful from the ADA if true
#ADA2026
And FIND CKD is live already on NEJM
www.nejm.org/doi/full/10....
#ERA26
Crazy happenings at the #ADA26
Cops show up, snatch papers and shove scientists out
www.medpagetoday.com/special-repo...
Researchers told they could no longer attend the annual scientific sessions
The CEO of the American Diabetes Association is Charles D. "Chuck" Henderson. The Chief Medical and Scientific Officer is Rita Rastogi Kalyani. They should be ashamed of themselves.
Atrasentan reduced proteinuria and preserved kidney function after 2·5 years. This effect was present with or without concomitant SGLT2 inhibitor use. Atrasentan was well tolerated.
Program / Unit Description The Division of Infectious Diseases & International Medicine at the University of Minnesota is a globally recognized leader in clinical research and implementation scien...
In randomized trials, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease (CKD)...
NephMadness 2026 is still fresh in our memories, but it’s already time to start thinking about NephMadness 2027! Which topics would you like to see in next year’s edition of the madness…
